Affiliation:
1. Department of Pharmacy Services, Hartford Hospital, Connecticut 06115.
Abstract
The bioavailability of ciprofloxacin after its administration through a nasogastric (NG) feeding tube was studied in six healthy volunteers. Each subject received, on separate occasions, an intact 750-mg ciprofloxacin tablet, a crushed tablet as a suspension through an NG tube, and a crushed tablet as a suspension through an NG tube while receiving enteral feeding. No statistically significant differences were observed in the area under the curve, maximum concentration in serum, and time to peak concentration among these three modes of administration. These findings suggest that ciprofloxacin is well absorbed after administration via an NG tube (compared with an orally administered intact tablet) even in the presence of enteral feeding.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference11 articles.
1. Bergan T. S. B. Thorsteinsson R. Solberg L. Bjornskau I. M. Kolstad and S. Johnsen. 1987. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses. Am. J. Med. 82(Suppl. 4A):97-102.
2. Absolute oral bioavailability of ciprofloxacin;Drbsano G. L.;Antimicrob. Agents Chemother.,1986
3. Fleming L. W. T. A. Moreland W. K. Stewart and A. C. Scott. 1986. Ciprofloxacin and antacids. Lancet ii:249.
4. Effect of aluminum hydroxide and calcium carbonfle antacids on ciprofloxacin bioavailability;Frost R. W.;Clin. Pharmacol. Ther.,1989
5. Gibaldi M. and D. Perrier. 1982. Pharmacokinetics 2nd ed. p. 409-417. Marcel Dekker Inc. New York.
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Relative bioavailability of fedratinib through various alternative oral administration methods in healthy adults;Cancer Chemotherapy and Pharmacology;2023-11-13
2. Developing guidance for feeding tube administration of oral medications;Journal of Parenteral and Enteral Nutrition;2023-03-22
3. Drug-Food Interactions;Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions;2018
4. Mechanisms of Drug Interactions I: Absorption, Metabolism, and Excretion;Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions;2018
5. Quinolones;Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions;2018